Promising preclinical findings reported for PI-88; phase I testing begins next month Oct. 13, 1998 No Comments
Gene therapy targeting Tie2 receptor tyrosine kinase evaluated as antiangiogenic strategy Oct. 13, 1998 No Comments
Targeted Genetics initiates phase II trials for proprietary gene therapy compound Oct. 8, 1998 No Comments
Onconase and proteasome inhibitors have synergistic antitumor activity, even in resistant tumors Oct. 8, 1998 No Comments
ADIR presents two new series of ellipticine derivatives with improved profiles Oct. 7, 1998 No Comments